Juan Pablo Horcajada

Juan Pablo Horcajada is an Honorary Associate Professor at the UQ Centre for Clinical Research, The University of Queensland. His research focuses on infectious diseases, antimicrobial resistance, and clinical microbiology, with emphasis on multidrug-resistant Gram-negative pathogens like Pseudomonas aeruginosa and ESBL-producing Enterobacterales. He investigates therapeutic strategies, including novel antibiotic combinations and pharmacokinetic/pharmacodynamic optimization, to address challenges in severe infections such as bacteremia, pneumonia, and endocarditis.

His epidemiological studies track antimicrobial resistance trends and healthcare-associated infections across community and hospital settings. Recent work leverages advanced diagnostic tools, including biosensors and immunological assays, to improve infection prognosis and management. Collaborative multinational projects underpin his contributions to clinical guidelines and stewardship programs aimed at optimizing patient outcomes globally.

Horcajada's publications highlight consistent themes: combating antibiotic resistance through innovative therapies, surveillance of emerging pathogens, and translational research bridging laboratory findings with clinical practice. His work spans critical care, pharmacology, and public health, addressing urgent challenges in infectious disease management.